摘要
背景:在衰老和年龄相关疾病如阿尔茨海默氏病(AD)中,学习能力下降。大脑细胞信号传导紊乱可能是认知衰退的基础。最近发生在退化神经元中的磷酸化/去磷酸化失衡与一种或多种信号转导途径的异常活性有关。已知AD与改变的神经元Ca2 +动态平衡相关,因为Ca2 +在受影响的神经元中积累,导致功能受损。信号转导途径参与Ca2 +代谢和蛋白质磷酸化调节越来越明显。围绕着信号转导系统在包括神经退行性疾病在内的许多人类疾病中的作用,特别是与磷酸肌醇(PI)途径和AD相关的系统有关的兴趣日益增加。 PI信号转导途径起着至关重要的作用,涉及多种细胞功能,如激素分泌,神经递质信号转导,细胞生长,膜运输,离子通道活性,细胞骨架调节,细胞周期控制,凋亡,细胞和组织极性,并有助于调节神经组织中的Ca2 +水平。 结论:一些观察表明,PI特异性磷脂酶C(PLC)酶可能参与神经传递的改变。为了理解在AD进展期间脑形态学变化过程中募集的信号传导途径的作用和时机,可能有助于阐明疾病的发病机理,为预后提炼和/或新的分子治疗策略铺平道路。
关键词: 磷脂酶C,阿尔茨海默病,磷酸肌醇信号传导,预后,诊断,发病机制
Current Alzheimer Research
Title:The Phosphoinositide Signal Transduction Pathway in the Pathogenesis of Alzheimer’s Disease
Volume: 15 Issue: 4
关键词: 磷脂酶C,阿尔茨海默病,磷酸肌醇信号传导,预后,诊断,发病机制
摘要: Background: During aging and in age-associated disorders, such as Alzheimer's Disease (AD), learning abilities decline. Probably, disturbances in signal transduction in brain cells underlie the cognitive decline. The phosphorylation/dephosphorylation imbalance occurring in degenerating neurons was recently related to abnormal activity of one or more signal transduction pathways. AD is known to be associated with altered neuronal Ca2+ homeostasis, as Ca2+ accumulates in affected neurons leading to functional impairment. It is becoming more and more evident the involvement of signal transduction pathways acting upon Ca2+ metabolism and phosphorylation regulation of proteins. A growing interest raised around the role of signal transduction systems in a number of human diseases including neurodegenerative diseases, with special regard to the systems related to the phosphoinositide (PI) pathway and AD. The PI signal transduction pathway plays a crucial role, being involved in a variety of cell functions, such as hormone secretion, neurotransmitter signal transduction, cell growth, membrane trafficking, ion channel activity, cytoskeleton regulation, cell cycle control, apoptosis, cell and tissue polarity, and contributes to regulate the Ca2+ levels in the nervous tissue.
Conclusion: A number of observations indicated that PI-specific phospholipase C (PLC) enzymes might be involved in the alteration of neurotransmission. To understand the role and the timing of action of the signalling pathways recruited during the brain morphology changes during the AD progression might help to elucidate the aetiopathogenesis of the disease, paving the way to prognosis refinement and/or novel molecular therapeutic strategies.
Export Options
About this article
Cite this article as:
The Phosphoinositide Signal Transduction Pathway in the Pathogenesis of Alzheimer’s Disease, Current Alzheimer Research 2018; 15 (4) . https://dx.doi.org/10.2174/1567205014666170829100230
DOI https://dx.doi.org/10.2174/1567205014666170829100230 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of PEDF in Tumor Growth and Metastasis
Current Molecular Medicine Toxicity Mechanism of Gadolinium Oxide Nanoparticles and Gadolinium Ions in Human Breast Cancer Cells
Current Drug Metabolism Heat Shock Protein 90 Inhibitors as Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Vitamin D and miRNAs in Cancer
Current Gene Therapy HSF1 as a Cancer Biomarker and Therapeutic Target
Current Cancer Drug Targets Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Current Molecular Medicine MicroRNA-212-3p Attenuates Neuropathic Pain via Targeting Sodium Voltage-gated Channel Alpha Subunit 3 (NaV 1.3)
Current Neurovascular Research The Role of Non-coding Genome in Cancer-associated Fibroblasts; Stateof- the-Art and Perspectives in Cancer Targeted Therapy
Current Drug Targets Structure-Based Virtual Screening for the Identification of High Affinity Compounds as Potent VEGFR2 Inhibitors for the Treatment of Renal Cell Carcinoma
Current Topics in Medicinal Chemistry Regulation of Tumor Angiogenesis by the Immune System
Current Angiogenesis (Discontinued) Induction of Thyroid Neoplasm Following Plant Medicine Marine Algae (Sargassum): A Rare Case and Review of the Literature
Current Pharmaceutical Biotechnology An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design Promises and Challenges of Adult Stem Cells in Cancer Therapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision
Anti-Cancer Agents in Medicinal Chemistry NF-κB Decoy Oligodeoxynucleotides Inhibits Kupffer Cell Activation
Current Signal Transduction Therapy Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy Heat Shock Proteins in Cancer: Signaling Pathways, Tumor Markers and Molecular Targets in Liver Malignancy
Protein & Peptide Letters Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Current Pharmaceutical Biotechnology